LAS VEGAS--(BUSINESS WIRE)--Oct 31, 2023--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (鈥淧harmaCyte鈥� or the 鈥淐ompany鈥�) provides an update on its investigation of its Cell-in-a-Box technology and initial next steps in development. Following a comprehensive scientific review of amassed data, ...
WOBURN, Mass.--(BUSINESS WIRE)--Oct 31, 2023--Sanguine Biosciences, a leading biospecimen procurement services company that empowers patients to accelerate precision medicine and cell and gene therapy research and development, today announced that it secured $10 million in credit financing from ...
CHICAGO--(BUSINESS WIRE)--Oct 31, 2023--The Misophonia Research Fund (MRF), an initiative of the REAM Foundation, demonstrates how $10 million in research investment can spur the growth of a new scientific field, drive the initiation and progress of research studies, and deliver long-awaited ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct 30, 2023--ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines <em>,</em> today announced it will present preclinical data demonstrating novel and proprietary lipid nanoparticle (LNP)-based ...
NEW YORK--(BUSINESS WIRE)--Oct 30, 2023--St. John's University, a renowned university known for its commitment to providing excellence in education, is proud to announce a new partnership with Perspectus, a Colorado-based leader in virtual reality (VR) technology. This collaboration will ...
SAN RAMON, Calif.--(BUSINESS WIRE)--Oct 30, 2023--The MUSE Creative Awards, which honor creative and design professionals, announced their 2023 winners on October 13 th, and despite more than 10,000 entries worldwide, the jury panel comprised of more than 60 industry professionals, from ...
